Question normal

Dr. Druker is a prototypal example of a physician scientist and all that can be achieved in a career in medicine and science. Don’t miss this opportunity to hear the story of imatinib from Dr. Druker himself as well as hear his advice for success as a physician scientist!

APSA is excited to announce our spring 2017 keynote interactive session with Dr. Brian Druker, an icon in oncology and precision medicine. Dr. Druker’s research led to the development of imatinib, the first clinically approved drug specifically targeted the molecular defect of a cancer. Imatinib transformed CML from a devastating and fatal cancer to a disease that can be held in long-term remission with a well-tolerated oral medication.

Please join us on March 22, 2017 at 5:00pm EDT. Call in information is below:

Interactive Session with Dr. Brian Druker
Wed, Mar 22, 2017 5:00 PM - 6:00 PM EDT

Please join my meeting from your computer, tablet or smartphone.
lnk.al/3Ogm

You can also dial in using your phone.
United States: +1 (872) 240-3412
Access Code: 182-533-197